In this issue:
- Rifaximin for alcoholic hepatitis
- Accuracy of point-of-care or dried blood spot analysis of HCV RNA
- Machine learning models to predict hepatocellular carcinoma
- Sustained virological response to glecaprevir/ pibrentasvir
- Predictors of durable functional cure after PEG-IFN
- Hepatitis E virus resistant to alcohol-based disinfectants
- Long-term renal safety with tenofovir vs entecavir
- Liver steatosis and liver stiffness measurement
- 3-antigen vs a single-antigen hepatitis B vaccine
- Management of HBV reactivation using HB core-related antigen assay
Please login below to download this issue (PDF)